The power of BRCA testing in ovarian cancer patients
Abstract
This observational cohort study, conducted across seven hospitals in the United States, examines the feasibility and practical application of BRCA1 and BRCA2 mutation testing in newly diagnosed ovarian cancer (OC) patients. The purpose was to determine whether genetic testing could facilitate more personalized patient care and improve diagnostic and treatment processes for patients and doctors. The study found that incorporating BRCA mutation testing was practical and feasible, highlighting the importance of understanding your genetic health. Early identification of mutations can lead to preventative measures, improving patient outcomes and contributing to the early detection of ovarian cancer.
Primary Faculty Mentor Name
Melissa Pespeni
Status
Undergraduate
Student College
College of Agriculture and Life Sciences
Program/Major
Biology
Primary Research Category
Life Sciences
The power of BRCA testing in ovarian cancer patients
This observational cohort study, conducted across seven hospitals in the United States, examines the feasibility and practical application of BRCA1 and BRCA2 mutation testing in newly diagnosed ovarian cancer (OC) patients. The purpose was to determine whether genetic testing could facilitate more personalized patient care and improve diagnostic and treatment processes for patients and doctors. The study found that incorporating BRCA mutation testing was practical and feasible, highlighting the importance of understanding your genetic health. Early identification of mutations can lead to preventative measures, improving patient outcomes and contributing to the early detection of ovarian cancer.
